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DONALD P. LOMBARDI, M.D., N. CARY ENGLEBERG, M.D., m7kb0f-, Michigan 
PUIWO!~ In the 197Os, blood culture for obli- 
gate anaerobic bacteria became routine in most 
United States hospitals. Since then, various au- 
thorities have reported isolation of obligate an- 
aerobes in 5% to 25% of blood cultures. Our ex- 
perience suggests a much lower frequency; 
therefore, we retrospectively assessed the occur- 
rence and significance of these cultures at our 
institutions. 
PATIENTSANDMETHODS: Sixty-six patients at 
the University of Michigan Hospitals (UMH) 
and nine patients at the Ann Arbor Veteran’s 
Administration Medical Center (AAVAMC) had 
one or more blood cultures positive for an obli- 
gate anaerobe between July 1,1987, and Decem- 
ber 31,1988. Their medical records were re- 
viewed retrospectively. 
RESULTS: The proportion of positive blood cul- 
tures yielding obligate anaerobes was 3.2% at 
the UMH and 1.8% at the AAVAMC. The inci- 
dences of clinically significant anaerobic bacte- 
remia at the two hospitals were 0.68 and 0.54 
cases per 1,000 patient admissions. Among the 40 
patients from whom significant isolates were ob- 
tained, 15 (38%) had a fatal outcome. Z?acte- 
roides and ClostSlium species accounted for 
90% of the isolates and all of the fatal cases. The 
source for anaerobic bacteremia was usually ob- 
vious; 30 of the 40 patients were given empiric 
antibiotic therapy for anaerobes. The gastroin- 
testinal tract was the source in two thirds of the 
cases and was clearly implicated as the source of 
80% of the fatal bacteremias. 
CONCLUSIONS: The frequency of anaerobic bac- 
teremia in our hospitals is much lower than was 
suggested in several large studies during the 
197Os, probably reflecting a real decline in the 
incidence. The clinical features of our cases are 
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similar to those of previous studies, and the mor- 
tality is still high despite the use of antibiotics 
effective against anaerobes. Since most patients 
were thought to have anaerobic infections at the 
time that cultures were obtained, they were usu- 
ally treated empirically. Subsequent blood cul- 
tures positive for anaerobes infrequently influ- 
enced clinical management. 
D uring the late 1960s and early 197Os, when im- provements in isolation techniques for obli- 
gate anaerobes were introduced, several large stud- 
ies drew attention to the potential significance of 
anaerobic bacteremias [l-6]. Subsequently, culti- 
vation for strict anaerobes has become a routine 
part of the clinical evaluation for bacteremia in 
most large hospitals. The frequency of anaerobic 
bacteremia was estimated at-and is currently re- 
ported in four major textbooks of medicine to be 
-between 5% and 25% [7-lo]. However, recent ex- 
perience at our hospitals suggested a much lower 
isolation frequency than the widely quoted reports. 
Therefore, we undertook a retrospective chart re- 
view at the University of Michigan Hospitals 
(UMH) and the Ann Arbor Veteran’s Administra- 
tion Medical Center (AAVAMC) in order to evalu- 
ate the incidence and clinical features of anaerobic 
bacteremia and to reassess the impact of this diag- 
nosis on patient management. 
PATIENTS AND METHODS 
UMH consists of six inpatient facilities (Univer- 
sity Hospital, Mott Children’s Hospital, Women’s 
Hospital, Holden Prenatal Hospital, Kellogg Eye 
Center, and the Child Psychiatric Center) that pro- 
vide tertiary health care for up to 888 patients. All 
six facilities are serviced by a single microbiology 
laboratory. At these facilities, blood samples are 
routinely cultured using both a lysis-centrifugation 
tube (DuPont Co., Wilmington, Delaware) for aer- 
obes and an unvented vacuum bottle containing 
supplemented peptone broth (Becton Dickinson 
Vacutainer Systems, Rutherford, NJ) for aerobes 
and anaerobes. The peptone broth bottles with 
signs of growth are subcultured under aerobic and 
anaerobic conditions, and isolates are identified by 
standard methods. Bottles without signs of growth 
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are subcultured aerobically and anaerobically on 
Days 3 and 6 and held for a total of 8 days incuba- 
tion before they are discarded. 
AAVAMC, a neighboring 488-bed referral center, 
utilizes the BacTec (Becton Dickinson Diagnostic 
Instrument Systems, Towson, Maryland) automat- 
ed radiometric sampling system for blood cultures. 
A blood culture “set” consists of two or three bot- 
tles, one for aerobes, one for anaerobes, and one for 
patients receiving antibiotics (BacTec 6B, 7D, and 
16B media, respectively). Any bottle having a sig- 
nificant growth index is subcultured anaerobically. 
Those having no detectable growth after 8 days are 
discarded. Blind subcultures are not routinely 
performed. 
tive blood culture had the same isolate from multi- 
ple cultures. At the time of the bacteremia, most of 
these patients were on the Surgical and Medical 
Services (13 and 10 patients, respectively). The re- 
maining cases occurred in patients on the Obstet- 
rics/Gynecologic (4), Pediatric (3), Urologic (a), and 
Emergency (1) Services. The overall incidence of 
clinically significant anaerobic bacteremia at UMH 
was 0.68 cases per 1,000 hospital admissions. 
All positive blood cultures between July 1,1987, 
and December 31,1988, recorded by the microbiolo- 
gy laboratories at the two hospitals were reviewed 
for study. Patients with obligate anaerobes isolated 
from their blood cultures were identified, and their 
medical records were reviewed. Charts were re- 
viewed with attention to age, sex, clinical service, 
number of positive cultures, clinical presentation, 
probable portal of entry, antibiotic treatment, com- 
plications (e.g., jaundice, metastatic abscesses, 
thrombophlebitis), maximum temperature, white 
blood cell count, presence of septic shock, mortali- 
ty, and temporal association with a surgical or inva- 
sive diagnostic procedure. Since we thought that 
the physicians caring for the patients were in the 
best position to assess whether a bacterial isolate 
from the blood was clinically significant, culture 
isolates were defined as “clinically significant” or 
“contaminants” based on the physician of record’s 
judgment, either as stated in writing or as indicated 
by specific actions taken in response to the culture 
(i.e., specific therapy versus no therapy). In addi- 
tion, each of the 75 cases was reviewed by us, and 
there was complete agreement in the assessment of 
the clinical significance of the cultures with the 
physician of record. 
During the same time period at the AAVAMC, 
12,879 patients were admitted. A total of 6,594 
blood cultures were obtained, of which 782 (11.9%) 
were positive for bacteria or fungi. Fourteen of 
these cultures yielded obligate anaerobes (1.8% of 
the positive blood cultures); however, only 12 of 
these (i.e., 86% of the anaerobe-positive blood cul- 
tures) were clinically significant isolates. These 12 
significant cultures were obtained from seven pa- 
tients; four were Medical Service inpatients, two 
were Surgical Service inpatients, and one patient 
was in the emergency room at the time the bacter- 
emia developed. The overall incidence of clinically 
significant anaerobic bacteremia at the AAVAMC 
was 0.54 cases per 1,000 hospital admissions. 
Microbiology of Anaerobic Bacteremia 
RESULTS 
Frequency and Incidence of Anaerobic Bacteremia 
During the 18-month period encompassed by our 
review, 48,645 patients were admitted to the UMH, 
and 31,758 blood cultures were drawn. Bacterial or 
fungal isolates were obtained from 2,712 blood cul- 
ture sets (8.5%). Eighty-six cultures (3.2% of the 
positive cultures) from 66 patients yielded obligate 
anaerobes. However, only 51.of these anaerobic iso- 
lates (i.e., 59% of the blood cultures positive for 
obligate anaerobes) were clinically significant; the 
remainder were determined to be contaminants. 
The 51 significant isolates were cultured from 33 
patients. Those patients with more than one posi- 
A variety of obligate anaerobes were grown from 
the clinically significant blood cultures, although 
Bacteroides sp. accounted for 65% of the isolates 
(Table I). The two most common species were Bac- 
teroides fragilis (from 12 patients) and Bacteroides 
thetaiotaomicronlovatus group (from eight pa- 
tients). Cultures from 11 patients yielded Clostridi- 
urn sp., with Clostridium septicum and Clostridi- 
urn perfringens isolated from four patients each. 
Three patients had Fusobacterium isolated from 
culture. One patient had polymicrobial anaerobic 
sepsis with B. fragilis and Fusobacterium morti- 
ferum, and four patients had a facultative isolate, in 
addition to an anaerobic isolate, from blood cul- 
tures taken during the same septic episode. Most of 
the isolates from contaminated blood cultures were 
Proprionibacterium acnes. This species accounted 
for 30 of the 37 contaminant isolates that were tak- 
en from 29 patients (81% of all anaerobic contami- 
nants). Single isolates of Veillonella sp., pepto- 
streptococcus, and B. distasonis, as well as two iso- 
lates each of B. melaninogenicus and Clostridium 
sp., were also judged to be contaminants by the 
physicians in charge. 
Clinical Presentation 
Patients with anaerobic bacteremia ranged from 
7 to 82 years of age (mean = 54 years; median = 59 
years). Males (17 patients) and females (16 pa- 
tients) were equally affected at UMH; all of the 
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TABLE I 
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1 Oil 
Veil/one//a species 1 Oil 
Peptostreptococcus asaccharolyticus 1 Oil 
Untypable 1 O/l 
Total 
iumber of deaths/total number of patients with the isolate. 
51 12133 12 317 
Ine patient had polymicrobial anaerobic sepsis with B. fragilis and F. mortiferum, 
AAVAMC patients were men. Data summarizing 
the clinical presentation, selected laboratory find- 
ings, and clinical complications in cases of anaero- 
bic bacteremia are summarized in Table II. Al- 
though a majority of bacteremic patients were 
febrile, only one fifth presented with septic shock. A 
surgical or invasive diagnostic procedure preceded 
the development of bacteremia in 35% of the pa- 
tients. Moreover, since many of the patients had 
undergone recent contaminated or clean-contami- 
nated surgery, cultures from other sites, such as 
abscesses or wounds, were frequently positive for 
anaerobic organisms. Direct complications of an- 
aerobic bacteremia were uncommon. No metastatic 
abscesses were found, and only two cases of nonsep- 
tic thrombophlebitis were diagnosed. 
For nearly all of the patients, there was an obvi- 
ous source for the anaerobic bacteremia (Table 
III). The putative portals of entry correlated well 
with those body surfaces on which anaerobes make 
up the predominant flora, i.e., the gastrointestinal 
tract, the female genitourinary tract, skin, and oral 
mucosa. Two thirds of bacteremic patients had ob- 
vious intra-abdominal processes that compromised 
the intestinal mucosal barrier. In a majority of these 
cases, the structural integrity of the abdominal vis- 
cera was compromised, either requiring surgical re- 
pair or as a result of a surgical procedure. In no case 
was the abdominal source occult. Among six pa- 
tients with skin as the presumed portal of entry, 
there were three cases of spontaneous clostridial 
myonecrosis and two cases of a forearm abscess at 
an injection site in an intravenous drug abuser. The 
bacteremic source in these cases was also immedi- 
ately apparent. Other sources for anaerobic bacter- 
emia (e.g., genitourinary, oral) were decidedly rare. 
TABLE II 
Clinical Characteristics of Anaerobic Bacteremia, UMH and AAVAMC, 
July 1987 to December 1988 
Clinical presentation 
Fever (38.1”C [> 100.5”Fl) 
Localized anaerobic infection 
Postoperative fever 
Septic shock (SBP ~80 mm Hg) 
Laboratory findings 
Leukocytosis (WBC > lO,OOO/mm3) 
















SBP = systolic blood pressure;,WBC = white blood cell count. 
*Number of patients with the Indicated clinical feature/total number of patients from whose chart 
evaluable information could be ascertained concerning the Indicated feature. 
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TABLE Ill 
Source of Anaerobic Bacteremia, by Portal of Entry 
No. 
Gastrointestinal tract 25 
Perforated bowel 
Postoperative abscess or wound infection* ; 
GI neoplasms 3 
Hepatic cirrhosis 
Nary tract infections 2’ 
Pyogenic hepatic abscess 
Crohn’s disease exacerbation : 
lschemic bowel 
Diverticulitis (seeding pericardium) i 
Severe mucositis after Ara-C 1 
Skin 
Clostridial myonecrosis 3” 
Forearm abscess (IV drug user) 2 
Diabetic with dry gangrene 1 
Genitourinary tract 3 
Prostatic abscess with penile gangrene 1 
Endometritis 
Infected cervical cancer i 
Oral 
Periapical abscess i 
Uncertain 5 
Ovarian cancer with fever and neutropenia 
Acute lymphocytic leukemia with fever and neutropenia i 
CVA/aspiration pneumonia 
Lymphomat i 
Hemodialysis patient? 1 
I 
7, gastrointestinal; Ara-C = cytosine arabinoside; IV = intravenous; CVA = cerebravascular 
acaaenr. 
*Includes one patient with a postoperative anastomotic leak and one patient with an inadvertent 
intraoperativeenterotomy. 
TMedical record not available for review. 
In 35 (88%) of the 40 UMH cases, a source for the 
anaerobic blood isolate was easily discernable. 
Among the patients with uncertain sources for bac- 
teremia, two developed anaerobic bacteremia in as- 
sociation with fever and neutropenia during cancer 
chemotherapy, but neither had a clinically appar- 
ent focus of anaerobic infection. One of these two 
had ovarian carcinoma, and blood cultures obtained 
during a febrile, neutropenic episode grew an un- 
typable gram-negative, anaerobic bacillus. A third 
patient was known to have lymphoma, but the med- 
ical records pertinent to the episode of anaerobic 
bacteremia were not available. One patient had a 
cerebrovascular accident complicated by multiple 
episodes of aspiration pneumonia; the patient sus- 
tained a fall at a chronic care facility and subse- 
quently developed respiratory distress and Bacte- 
roides uniformis bacteremia (a possible oral 
source). The remaining patient was undergoing he- 
modialysis and developed B. fragilis bacteremia 
without a clear portal of entry. 
Outcome of Anaerobic Bacteremia 
Fifteen patients (38%) with anaerobic bacteremia 
died. All 15 patients who died had either Bacte- 
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roides or Clostridium bacteremia. Ten patients had 
Bacteroides bacteremia (42% mortality); five pa- 
tients had Clostridium bacteremia (45% mortality). 
Although anaerobic bacteremia is associated with a 
high fatality rate, anaerobic sepsis was not the im- 
mediate cause of death in most patients. Septic 
shock occurred in eight patients (20%); however, 
five of these patients had a fatal outcome. In only 
one patient was an anaerobe cultured from the 
blood within hours of death. This patient had acute 
lymphoblastic leukemia and presented to the UMH 
Emergency Room with signs of acute abdomen and 
septic shock and was found to have had a bowel 
perforation and C. septicum bacteremia. He had a 
cardiac arrest as antibiotics and vasopressors were 
being administered. Among the four other patients 
who died with septic shock, none had anaerobes 
isolated from their blood cultures within 24 hours of 
death. 
Apart from the septic shock, the only other possi- 
ble predictor of mortality in this study was the 
source of bacteremia. Among the 25 patients with a 
gastrointestinal source of bacteremia, 12 (48%) 
died, whereas only three (20%) of the 15 patients 
with other (or unknown) sources died; however, this 
difference was not statistically significant. Approxi- 
mately half (19 of 40) of the patients had some form 
of cancer at the time of their bacteremia, but this 
diagnosis did not confer a significantly worse prog- 
nosis; mortality was 42% in cancer patients and 33% 
in noncancer patients. 
All 15 fatal cases were treated with antimicrobial 
agents that have broad activity against anaerobes 
isolated at our hospitals (i.e., metronidazole, clinda- 
mycin, imipenem, or ticarcillin-clavulanate). Anti- 
biotic susceptibility data were available for six of 
the 15 fatal cases, and, in all six cases, the isolate 
was sensitive to the antibiotic used. We conclude, 
therefore, that the choice of inappropriate or inef- 
fective antibiotics was not a factor that contributed 
to mortality in this series of patients. 
Impact of Anaerobic Bacteremia on Patient 
Management 
We were interested to know what effect the diag- 
nosis of anaerobic bacteremia had on the care of 
these patients in order to assess the practical utility 
of routine anaerobic blood cultures. We, therefore, 
reviewed the records to determine whether the pos- 
itive culture report resulted in a change in the man- 
agement of the patient, and if so, whether the 
change significantly altered the clinical course and 
outcome. 
By retrospective chart review, we could establish 
with certainty in 29 of the 33 UMH cases and all 
seven of the AAVAMC cases whether or not antibi- 
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otics with broad activity against anaerobes were ad- 
ministered empirically (i.e., clindamycin, metroni- 
dazole, ,&lactams with extensive anti-anaerobic 
activity). In 30 of these 36 evaluable cases, empiric 
antibiotic therapy directed against anaerobes was 
used. Albeit in retrospect, we judged that 28 of the 
30 patients who received this therapy, and five of 
the six patients who did not receive empiric cover- 
age had initial clinical presentations that typically 
evoke suspicion of anaerobic infection. 
In only three cases did the culture result in a 
change in therapy that affected patient manage- 
ment. In the first case, a patient with hepatic cir- 
rhosis developed right upper quadrant abdominal 
pain, fever, and increased abdominal girth; he was 
treated empirically with ceftriaxone alone. When 
his blood cultures became positive for B. thetaio- 
taomicronlovatus, metronidazole was added to his 
treatment regimen. In the second case, the patient 
sustained an inadvertent enterotomy during a ne- 
phrectomy for renal cell carcinoma. The patient 
was treated intraoperatively and postoperatively 
with cephalothin and gentamicin, but after the 
blood cultures became positive for B. thetaiotaomi- 
cronlovatus, therapy was changed to include me- 
tronidazole. The third patient was a febrile, neutro- 
penic patient with acute lymphoblastic leukemia 
who had metronidazole added to empiric therapy 
with ceftazidime and tobramycin when the blood 
culture grew CZostridium ramnosum. The patient 
tolerated the anaerobic bacteremia well, as she was 
clinically improving without definitive anaerobic 
coverage for the 5 days required to grow the isolate 
from culture. Indeed, the anaerobic isolate may 
have been a contaminant in this case; however, 
since the culture result prompted therapeutic ac- 
tion on the part of the physician in charge, the iso- 
late was classified as significant by our predeter- 
mined criteria. 
incidence of bacteremia have been difficult to es- 
tablish. Although a series of frequently cited stud- 
ies from the Mayo Clinic in the early 1970s reported 
the frequency of obligate anaerobes in positive 
blood cultures to be 11.2% to 27% [3,5,12,13], other 
contemporary studies reported much lower isola- 
tion rates [14-161. Finegold [17] reviewed the litera- 
ture in 1975 and suggested that a generalized fre- 
quency might be 5% to 15% of all bacteremias. Since 
1975, several more research articles on the epidemi- 
ology of bacteremia in general hospital populations 
have been published in which the frequency or inci- 
dence of anaerobic organisms was measured or can 
be ascertained. In these more recent experiences, 
anaerobes still represent 1.8% to 17.3% of all posi- 
tive cultures (Table IV). However, the Mayo Clinic 
reported a decrease in the frequency of anaerobic 
bacteremia in recent years. The frequency shown in 
Table IV represents the cumulative experience over 
10 years; however, in data summaries from individ- 
ual years, anaerobes accounted for 17.5% of micro- 
organisms recovered from blood cultures in 1974, 
but only 7.4% of the positive cultures in 1984 1261. 
Most of the decline was due to a decrease in the 
isolation of Bacteroides sp. Comparable observa- 
tions were made in two more recent studies. A hos- 
pital-based study from New York City showed a 
decline in the proportion of blood cultures positive 
for Bacteroides sp. from 5.5% in 1981 to 1.7% in 
1988 [29]. Similarly, a nationwide, voluntary blood 
culture surveillance system in the United Kingdom 
reported a decline in the frequency of Bacteroides 
isolates from 5.8% in 1975 to 3.5% in 1980 [37]. 
In summary, blood culture results rarely led to 
the initiation of specific antibiotic therapy for an- 
aerobes, since most patients had an obvious source 
for their infection and were treated with anaerobic 
coverage empirically. In two of the cases in which a 
significant therapeutic change was made (the first 
two cases summarized above), the clinical settings 
were quite compatible with the eventual isolation of 
an anaerobic bacterium from blood. It is not possi- 
ble, in a retrospective analysis, to determine wheth- 
er the blood culture report influenced the choice or 
duration of antibiotic therapy that had been begun 
empirically. 
COMMENTS 
Although it is possible that the infrequent isola- 
tion of anaerobes reported in this study reflects 
relatively insensitive culture methodology, we con- 
sider this explanation unlikely, since comparable 
data were obtained from two independent hospital 
laboratories that use different blood culture sys- 
tems. It is also possible that the lower frequency is 
artifactual, resulting from lower rates of anaerobic 
contaminants or higher rates of either significant or 
contaminant isolates of aerobic or facultative bacte- 
ria in our hospitals. However, a comparison of the 
incidence rates of clinically significant anaerobic 
bacteremia belies this notion, since these rates are 
unaffected by other differences in blood culture iso- 
lations. Using a much more stringent definition of 
“clinical significance” than ours, Wilson and co- 
workers [12] found an incidence of 1.22 cases of 
significant anaerobic bacteremia per 1,000 admis- 
sions to the Mayo Clinic in the 1970s twice the rates 
in our study. 
Since cultivation of blood for obligate anaerobes 
was first evaluated in 1938 [ll], the frequency and 
On these grounds, we believe that the relatively 
low frequency and incidence of anaerobic bacter- 
emia in our hospitals represent real, and not artifac- 
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TABLE IV 
Studies of Bacteremia in General Hospitals Published After 1975: Occurrence of Obligate Anaerobics in Blood Culture 
Location, Cultures Positive 
Years Studied for Anaerobics 
Frequ;ry* 
0 Incidence? Reference 
U.S. hospitals 
Madison, Wisconsin, 1970-1973 
New Jersey, 1974-1975 
Denver, Colorado, 1975-1977 
Atlanta, Georgia (not stated) 





South Carolina, 1977-i981 
Washington, DC., and Bethesda, Maryland, 
1973-1985 
Rochester, Minnesota, 1974-1984 
Boston, Massachusetts, and Los Angeles, Califor- 
nia, 1979-1981 
Morgantown, West Virginia, and Denver, Colorado 
(not stated) 




























This study (both hospitals) 
Non-US. hospitals 
London, United Kingdom, 1972-1976 
Ibadan, Nigeria, 1976 
Great Britai?, 1969-1988 
Madrid, Spain, 1979-1981 
Kuwait, 1982-1983 
Oviedo, Spain, 1981-1985 
















krcent of all positive blood cultures with obligate anaerobic isolates. 
lumber of episodes of significant anaerobic septicemia per 1,000 hospital admissions. 
lnly Bacteroides species, Fusobacterium species, and anaerobic cocci included in data. 
hese studies reported the number of patients with anaerobic bacteremia and the proportion of bacteremic patients with anaerobes instead of culture data. 
tual, differences with past reports from other hospi- 
tals. We cannot compare our current results with 
those obtained in earlier years, since the culture 
techniques used prior to the 1980s were significant- 
ly different at both hospitals. However, our data, 
taken in context with those from the Mayo Clinic 
and from New York, provide strong grounds for 
speculation that the incidence of anaerobic bacter- 
emia has actually decreased since the 1970s. One 
may ask whether our patient population is intrinsi- 
cally at less risk of anaerobic bacteremia, or wheth- 
er some aspects of local medical practice might have 
influenced the occurrence or ascertainment of these 
cases. We favor the latter notion, since there is no 
epidemiologic or geographic reason to accept the 
former. Indeed, the use of antimicrobial agents may 
well explain the differences. Agents used primarily 
for their activity against anaerobes, such as clinda- 
mycin and metronidazole, are among the most fre- 
quently prescribed antibiotics at our institutions, 
and many of the new broad-spectrum antibiotics 
that are used empirically in the treatment of noso- 
comial infections have excellent activity against ,& 
lactamase-producing Bacteroides species. Since 
these antibiotics are generally viewed as safe and 
effective, their use for early or empiric therapy may 
prevent some bacteremias or make physicians less 
prone to draw cultures when a focal source of infec- 
tion is known and has been cultured. Also, the adop- 
tion of new antibiotics for surgical prophylaxis may 
have affected the incidence of postoperative anaer- 
obic bacteremia. Unpublished data from the UMH 
indicate a decline in postoperative infection follow- 
ing colectomy during the late 1970s coincident with 
the adoption of cefoxitin in place of cefazolin for 
surgical prophylaxis (R. Fekety, personal 
communication). 
Although the incidence of anaerobic bacteremia 
may have declined in recent years, the clinical fea- 
tures of bacteremic patients are the same. As Gor- 
bath and Bartlett [38] pointed out, “A basic fact of 
our tenuous coexistence with our environment is 
that ‘life on man’ is predominantly anaerobic.” It is, 
therefore, not surprising that the clinical manifes- 
tations of anaerobic bacteremia are predictable giv- 
en the known niches of these organisms “on man” 
and that the vast majority of cases are associated 
with gastrointestinal pathology. About two thirds 
of the cases had a gastrointestinal focus as the por- 
tal of bacterial entry. Moreover, we found that in 
92% of the retrospectively evaluable cases, the clini- 
cal presentation or the nature of the underlying 
illness suggested possible involvement by anaerobic 
pathogens. In fact, when empiric antimicrobial 
therapy was used, broad activity against anaerobes 
was included in all but two instances. 
Despite advances in antimicrobial therapy, the 
mortality associated with anaerobic bacteremia was 
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high in our study. Earlier studies typically reported 
lower case-fatality rates (25% to 35%) for anaerobic 
bacteremia [12,21,38,39]. It has been suggested that 
the relatively low mortality may be attributable to 
the significant proportion of obstetric and gyneco- 
logic patients in these patient groups [21]. Chow 
and Guze [39] reviewed reports of Bacteroides bac- 
teremia in 1974 and found that obstetrical patients 
accounted for 20% to 30% of the cases but less than 
1% of the mortality. In our series, only 1 of 40 pa- 
tients was an obstetric patient, perhaps reflecting 
the recognition and early treatment of anaerobic 
infections in these patients. In contrast to earlier 
studies, nearly half of our patients had some form of 
malignancy. Patients with malignancies are at 
greater risk of mortality from bacteremia in general 
[21] and with Bacteroides in particular [39,40]. Giv- 
en the population differences, it is likely that the 
relatively high case-fatality rate in our study re- 
flects the severity of the precipitating pathologic 
processes. In our hospitals, anaerobic bacteremia 
can be viewed as a potential indicator of a severe 
underlying disorder, rather than as a primary 
pathologic process. 
Mortality did not appear to be due to a failure of 
anti-anaerobic antibiotic therapy per se. Our review 
showed that those patients who died had all re- 
ceived adequate antimicrobial therapy before 
death. Given the importance of surgical interven- 
tion in many anaerobic infections, the feasibility 
and timing of surgery might have been more rele- 
vant predictors of outcome; however, these aspects 
of care could not be evaluated accurately in our 
retrospective study. 
In considering the overall impact of the diagnosis 
of anaerobic bacteremia at our institutions, we con- 
clude that the isolation of obligate anaerobes from 
the blood may signal the presence of a serious un- 
derlying condition, usually in the gastrointestinal 
tract. However, cultivation of clinically significant 
anaerobes from the blood is an infrequent event in 
our hospitals. Moreover, anaerobic bacteremias 
typically occur in association with recognized, pre- 
disposing clinical conditions, and, consequently, 
their detection rarely results in a change of patient 
management or clinical outcome. 
ADDENDUM 
As this article went to press, data showing declin- 
ing rates of anaerobic bacteremia from two other 
sources appeared in the published literature. The 
proportion of bacteremias caused by anaerobes at 
the Mayo Clinic (Rochester, Minnesota) reportedly 
declined from 20.7% in 1974 to 10.5% in 1988 [41]. 
Similarly, the proportion of nosocomial bacte- 
remias caused by anaerobes declined from 7.2% 
during the years 1969 to 1979 to 4.5% during the 
years 1980 to 1990 at Guy’s and St. Thomas’ Hospi- 
tals, London, United Kingdom 1421. 
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